EP 1562586 A4 20071010 - METHODS OF USING AND COMPOSITIONS COMPRISING SELECTIVE CYTOKINE INHIBITORY DRUGS FOR TREATMENT, MODIFICATION AND MANAGEMENT OF PAIN
Title (en)
METHODS OF USING AND COMPOSITIONS COMPRISING SELECTIVE CYTOKINE INHIBITORY DRUGS FOR TREATMENT, MODIFICATION AND MANAGEMENT OF PAIN
Title (de)
VERFAHREN ZUR VERWENDUNG VON SELEKTIVENZYTOKIN-HEMMENDEN ARZNEIMITTELN UND DIESE ENTHALTENDE ZUSAMMENSETZUNGEN ZURBEHANDLUNG, MODIFIKATION UND KONTROLLE VON SCHMERZEN
Title (fr)
COMPOSITIONS CONTENANT DES MEDICAMENTS SELECTIFS INHIBITEURS DES CYTOKINES, DESTINEES A TRAITER, MODIFIER ET GERER LA DOULEUR, ET LEURS METHODES D'UTILISATION
Publication
Application
Priority
- US 0334005 W 20031024
- US 42100402 P 20021024
Abstract (en)
[origin: US2004087558A1] Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery, psychological or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
IPC 1-7
IPC 8 full level
A61K 31/10 (2006.01); A61K 31/19 (2006.01); A61K 31/192 (2006.01); A61K 31/40 (2006.01); A61K 31/405 (2006.01); A61K 31/445 (2006.01); A61K 31/485 (2006.01); A61K 31/573 (2006.01); A61K 31/60 (2006.01); A61K 45/06 (2006.01)
CPC (source: EP KR US)
A61K 31/10 (2013.01 - EP US); A61K 31/19 (2013.01 - EP US); A61K 31/192 (2013.01 - EP US); A61K 31/40 (2013.01 - EP KR US); A61K 31/405 (2013.01 - EP KR US); A61K 31/445 (2013.01 - EP US); A61K 31/485 (2013.01 - EP US); A61K 31/573 (2013.01 - EP US); A61K 31/60 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 25/02 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
- [X] US 5654323 A 19970805 - BRION JEAN-DANIEL [FR], et al
- [X] WO 0101986 A1 20010111 - LIPTON STUART A [US]
- [DA] US 5698579 A 19971216 - MULLER GEORGE W [US]
- See references of WO 2004037207A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
US 2004087558 A1 20040506; AU 2003284979 A1 20040513; AU 2003284979 B2 20080717; BR 0315593 A 20050906; CA 2503054 A1 20040506; CN 1731998 A 20060208; EP 1562586 A2 20050817; EP 1562586 A4 20071010; EP 2036553 A1 20090318; JP 2006505591 A 20060216; KR 20050072113 A 20050708; MX PA05004169 A 20050713; NZ 540026 A 20080430; NZ 566768 A 20091030; TW 200412943 A 20040801; WO 2004037207 A2 20040506; WO 2004037207 A3 20050210; ZA 200503241 B 20081231
DOCDB simple family (application)
US 69372203 A 20031023; AU 2003284979 A 20031024; BR 0315593 A 20031024; CA 2503054 A 20031024; CN 200380107547 A 20031024; EP 03779299 A 20031024; EP 08018323 A 20031024; JP 2004547196 A 20031024; KR 20057007018 A 20050422; MX PA05004169 A 20031024; NZ 54002603 A 20031024; NZ 56676803 A 20031024; TW 92129607 A 20031024; US 0334005 W 20031024; ZA 200503241 A 20031024